Review of NVP and HG and Early Pharmacotherapeutic Intervention
Open Access
- 24 November 2011
- journal article
- review article
- Published by Hindawi Limited in Obstetrics and Gynecology International
- Vol. 2012, 1-8
Abstract
NVP occurs in 50–90% of pregnancies, making it a common medical condition in pregnancy. Women present differently with any combination of signs and symptoms. It is appropriate to take the pregnancy-related versus nonpregnancy-related approach when determining the cause of nausea and vomiting but other causes should be considered. The most common etiologies for NVP include the hormonal changes associated with pregnancy, the physiologic changes in the gastrointestinal tract, and a genetic predisposition. Up to 10% of women will require pharmacotherapy to treat the symptoms of NVP despite conservative measures. ACOG currently recommends that a combination of oral pyridoxine hydrochloride and doxylamine succinate be used as first-line treatment for NVP if pyridoxine monotherapy does not relieve symptoms. A review of NVP and early pharmacotherapeutic management is presented due to the fact that NVP is largely undertreated, and investigations into the safe and effective pharmacotherapies available to treat NVP are lacking.Keywords
This publication has 68 references indexed in Scilit:
- High prevalence of severe nausea and vomiting of pregnancy and hyperemesis gravidarum among relatives of affected individualsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2008
- The association of psychosocial factors with nausea and vomiting during pregnancyJournal of Psychosomatic Obstetrics & Gynecology, 2008
- Risk Factors for Hyperemesis Gravidarum Requiring Hospital Admission During PregnancyObstetrics & Gynecology, 2006
- Validation studies of the Pregnancy Unique-Quantification of Emesis (PUQE) scoresJournal of Obstetrics and Gynaecology, 2005
- The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative studyBJOG: An International Journal of Obstetrics & Gynaecology, 2004
- Nausea and vomiting in pregnancy: The problem of perception—is it really a disease?American Journal of Obstetrics and Gynecology, 2002
- The Safety of Higher Than Standard Dose of Doxylamine‐Pyridoxine (Diclectin®) for Nausea and Vomiting of PregnancyThe Journal of Clinical Pharmacology, 2001
- Decrease of transplantability by the immunopotentiators, OK-432 and interleukin-2: Experiments on a human hepatoma cell line in nude miceEuropean Journal of Cancer and Clinical Oncology, 1989
- Nausea and vomiting in early pregnancyInternational Journal of Gynecology & Obstetrics, 1988
- Teratogen update: BendectinTeratology, 1983